Discovery & Development

How is the oral drug delivery field changing to cope with solubility and bioavailability issues?

Formulation continues to challenge the industry, but collaboration and new technologies can tackle the issues head on.

Orally dissolving tablets could be a good match for patients that dislike swallowing tablets.

Can the microbiome predict the likelihood of chemotherapy side effects?

The FDA has approved a pill with the ability to track patient compliance.

The solution to multiple drugs co-existing in a syringe may lie with microparticles

The industry requires reassurance on elemental impurities. How can media suppliers provide confidence in this area?

Respiratory drug development lags behind other therapeutic areas, but why?

Sitting Down With... Cornell Stamoran, Vice President of Corporate Strategy, Catalent Pharma Solutions, USA.

The nose is an open door that offers rapid access to different organs.